-2.png){kind=small}
-4.png){kind=small}
-3%20(1).png){kind=small}
Fast Acting CBD
At EquiCeutica, we’re not just making CBD—we’re revolutionizing it.
With our breakthrough Liposomal-Nano Encapsulation, we’ve created pharma-grade Fast Acting CBD that delivers up to 5x better absorption, faster results, and pinpoint precision for both animals and humans.
We're one of the few companies worldwide focused on regulatory-approved CBD for horses, dogs, cats, and humans—crafted using cutting-edge science and backed by peer-reviewed research.
No fluff. Just real, effective, Fast Acting CBD with unmatched bioavailability and minimal liver breakdown.
Products
What Makes EquiCeutica Different?
What sets EquiCeutica apart? We’re harnessing the latest advancements in science to create pharma-grade CBD products designed specifically for horses, dogs, cats, and humans. Our formulations and dosages are backed by peer-reviewed research, ensuring unmatched effectiveness.
Through cutting-edge development, we’ve created a superior CBD product with exceptional bioavailability—delivering targeted relief while minimizing liver metabolism and residue. Partnering with a leading UK MHRA-accredited manufacturer for human and veterinary medications, we use the same scientifically validated CBD distillate studied for both equine, canine, and feline.
Plus, we’re pioneering liposomal nano-encapsulation technology, setting a new standard in the veterinary & human spaces for enhanced absorption and effectiveness.
Pharmaceutical Grade
Peer-reviewed Research
Liposomal Encapsulation
Third-Party Tested
Check Out Our Informative Podcasts
“Balou, an 11 year old gelding, ridden by Andrew Hoy was unable to retain fitness. In April 2023 he was treated with EquiCeutica CBD and recovered his condition within 3 weeks with a successful return to international competition"
Nelson Pessoa, Olympic Equestrian and Trainer (Balou is now ridden by Germany's Michael Jung)
Studies Conducted by Dr Rodrigo Zamith Cunha VM DVM MSc – EquiCeutica Chief Scientific and Veterinary Officer
Rodrigo’s work has resulted in more than eight scientific publications, listed below with a link displayed.
Publications (https://www.researchgate.net/scientific-contributions/Rodrigo-Zamith-Cunha-2225466915)
The Expression of Cannabinoid and Cannabinoid-Related Receptors on the Gustatory Cells of the Piglet Tongue. Molecules · Sep 28, 2024
Expression of Cannabinoid Receptors in the Trigeminal Ganglion of the Horse
Int J Mol Sci. 2023 · Nov 3, 2023
Endocannabinoid System Receptors at the Hip and Stifle Joints of Middle-Aged Dogs: A Novel Target for the Therapeutic Use of Cannabis sativa Extract in Canine Arthropathies
Animals · Sep 6, 2023
Expression of cannabinoid (CB1 and CB2) and cannabinoid-related receptors (TRPV1, GPR55, and PPARα) in the synovial membrane of the horse metacarpophalangeal joint
Frontiers in Veterinary Medicine · Mar 2, 2023
The use of cannabidiol as a novel treatment for oral stereotypic behaviour (crib-biting) in a horse
Journal of Veterinary and Animal Science · Feb 9, 2023
Cannabinoid receptors in the inflammatory cells of canine atopic dermatitis.
Frontiers Veterinary Science · Sep 15, 2022
Distribution of cannabinoid receptors in keratinocytes of healthy dogs and dogs with atopic dermatitis
Frontiers Veterinary Science · Jun 20, 2022